State Street Corp Acquires 56,725 Shares of CME Group Inc. $CME

Posted by Casey Walker on Jun 13th, 2026

State Street Corp increased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 0.4% during the 4th quarter, Holdings Channel reports. The fund owned 16,144,525 shares of the financial services provider’s stock after buying an additional 56,725 shares during the quarter. State Street Corp’s holdings in CME Group were worth $4,408,747,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Asset Dedication LLC boosted its stake in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the last quarter. FNY Investment Advisers LLC bought a new position in CME Group during the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC bought a new position in CME Group during the 4th quarter worth approximately $28,000. Global Wealth Strategies & Associates boosted its stake in CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 100 shares during the last quarter. Finally, Legacy Wealth Managment LLC ID boosted its stake in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 71 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $269.53 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a twelve month low of $244.56 and a twelve month high of $329.16. The firm’s 50 day moving average price is $284.79 and its two-hundred day moving average price is $288.07. The firm has a market cap of $97.67 billion, a P/E ratio of 23.00, a PEG ratio of 2.93 and a beta of 0.21.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the previous year, the firm posted $2.80 earnings per share. The business’s revenue was up 14.5% on a year-over-year basis. On average, analysts forecast that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is presently 44.37%.

Insider Activity

In other news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This trade represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 44,044 shares of company stock worth $13,297,507 over the last ninety days. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CME shares. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Jefferies Financial Group reduced their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Keefe, Bruyette & Woods started coverage on shares of CME Group in a research note on Wednesday, April 8th. They set a “market perform” rating and a $305.00 price objective on the stock. Raymond James Financial lifted their price target on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Finally, Morgan Stanley cut their price target on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research note on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $305.71.

Get Our Latest Stock Report on CME Group

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME announced four new E-mini futures contracts tied to broad-market equity benchmarks, plus new Micro E-mini options on the S&P 500 and Nasdaq-100. These launches could attract more trading volume by giving investors additional, lower-cost ways to hedge and gain market exposure. CME Group to Expand Equity Index Suite with Launch of Four New E-mini Futures Contracts
Positive Sentiment: The company also said it will expand 24/7 trading for WTI crude oil and gold, which could improve price discovery and make CME’s metals and energy products more attractive to global traders operating outside normal market hours. CME Group to Expand 24/7 Trading for WTI Crude Oil and Gold
Positive Sentiment: CME launched Nasdaq CME Crypto Index futures and is moving deeper into digital-asset derivatives, giving investors regulated exposure to major cryptocurrencies and potentially opening another growth avenue for the exchange. CME Group Launches Crypto Index Futures Tracking Bitcoin, Solana and XRP
Neutral Sentiment: Erste Group Bank slightly raised its FY2026 EPS estimate for CME, signaling stable earnings expectations rather than a major change in outlook. MarketBeat report on CME estimate update
Negative Sentiment: Some commentary around the CFTC’s crypto oversight has raised concerns about regulatory pressure and market criticism, which could create uncertainty for CME’s expanding crypto-related products. CFTC’s Lone Chair Selig Expands Grip Over Crypto and Prediction Markets

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.